Skip to main content

Table 3 Expression of cell adhesion molecules ICAM-1 and HCAM (CD44s) in malignant carcinomas

From: Cell adhesion molecules’ altered profile in benign and malignant salivary gland tumors. The paradigm of beta4-integrin, desmoglein-2, ICAM-1 and CD44s

Type of tumor

ICAM-1

HCAM (CD44s)

Positivity

Pattern

Intensity

Positivity

Pattern

Intensity

ACC (n = 7)

III (1)

I (6)

M

M (3), M (luminal surface) (3)

+++

++

III

M

+++

EMYC (n = 3)

II (2)

I (1)

M (luminal cells/surface)

M (non-luminal cells)

++

I

M

(non-luminal cells)

+++

ADCC (n = 3)

(-) (2), I (1)

M

++

III

M

++

PLGA (n = 2)

II

M (luminal surface of luminal cells)

++

II

M (luminal central cells)

+++

MEC (n = 3)

II

M

++

III

M(epithelioid/intermediate cells)

+++

SDC (n = 3)

III (2)

I % (1)

C

M/C

++

+++

III (1)

I (2)

M

+++

++

SCC (n = 5) High grade (2)

Low grade (3)

I

III (1), I (2)

M

++

I

III

M

+

+++

LEPC (n = 2)

I (1), II (2)

M

+++

I (1), II (2)

M

++ , +++

ONC (n = 1)

0

M

++

II

M

++

MYEC (n = 1)

I

M

++

III

M

++

ANOS (n = 1)

III

M

++

0

M/C

+

  1. ΑCC Acinic cell carcinoma, EMYC Epithelial-myoepithelial carcinoma, ADCC Adenoid cystic carcinoma, PLGA Polymorphous low-grade adenocarcinoma, MEC Mucoepidermoid carcinoma, SDC Salivary ductal carcinoma, SCC Squamous cell carcinoma, LEPC Lymphoepithelial carcinoma, ONC Oncocytic carcinoma, MYEC Myoepithelial carcinoma, ANOS Adenocarcinoma not otherwise specified, n Number of cases, M Membranous, C Cytoplasmic